BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heriansyah T, Nur Chomsy I, Febrianda L, Farahiya Hadi T, Andri Wihastuti T. The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review. Sci Pharm 2020;88:55. [DOI: 10.3390/scipharm88040055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alsagaff MY, Mulia EPB. Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence. Indian Heart J 2021;73:757-9. [PMID: 34717930 DOI: 10.1016/j.ihj.2021.10.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S. Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers. Blood Press 2021;30:1-3. [PMID: 33349063 DOI: 10.1080/08037051.2021.1862483] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]